PortalPublikationenCanakinumab After Electrical Cardioversion in Patients With ...

Canakinumab After Electrical Cardioversion in Patients With Persistent Atrial Fibrillation: A Pilot Randomized Trial

Standard

Canakinumab After Electrical Cardioversion in Patients With Persistent Atrial Fibrillation: A Pilot Randomized Trial. / Krisai, Philipp; Blum, Steffen; Schnabel, Renate B; Sticherling, Christian; Kühne, Michael; von Felten, Stefanie; Ammann, Peter; Pruvot, Etienne; Albert, Christine M; Conen, David.

in: CIRC-ARRHYTHMIA ELEC, Jahrgang 13, Nr. 7, e008197, 07.2020.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Andere (Vorworte u.ä.) › Forschung

Harvard

Krisai, P, Blum, S, Schnabel, RB, Sticherling, C, Kühne, M, von Felten, S, Ammann, P, Pruvot, E, Albert, CM & Conen, D 2020, 'Canakinumab After Electrical Cardioversion in Patients With Persistent Atrial Fibrillation: A Pilot Randomized Trial', CIRC-ARRHYTHMIA ELEC, Jg. 13, Nr. 7, e008197. https://doi.org/10.1161/CIRCEP.119.008197

APA

Krisai, P., Blum, S., Schnabel, R. B., Sticherling, C., Kühne, M., von Felten, S., Ammann, P., Pruvot, E., Albert, C. M., & Conen, D. (2020). Canakinumab After Electrical Cardioversion in Patients With Persistent Atrial Fibrillation: A Pilot Randomized Trial. CIRC-ARRHYTHMIA ELEC, 13(7), [e008197]. https://doi.org/10.1161/CIRCEP.119.008197

Vancouver

Krisai P, Blum S, Schnabel RB, Sticherling C, Kühne M, von Felten S et al. Canakinumab After Electrical Cardioversion in Patients With Persistent Atrial Fibrillation: A Pilot Randomized Trial. CIRC-ARRHYTHMIA ELEC. 2020 Jul;13(7). e008197. https://doi.org/10.1161/CIRCEP.119.008197

Bibtex

@article{0e17b3d67ac749f4b9177bc2bdeae858,
title = "Canakinumab After Electrical Cardioversion in Patients With Persistent Atrial Fibrillation: A Pilot Randomized Trial",
keywords = "Anti-Inflammatory Agents/adverse effects, Antibodies, Monoclonal, Humanized/adverse effects, Atrial Fibrillation/diagnosis, Double-Blind Method, Electric Countershock/adverse effects, Female, Heart Rate/drug effects, Humans, Male, Pilot Projects, Recurrence, Risk Factors, Time Factors, Treatment Outcome",
author = "Philipp Krisai and Steffen Blum and Schnabel, {Renate B} and Christian Sticherling and Michael K{\"u}hne and {von Felten}, Stefanie and Peter Ammann and Etienne Pruvot and Albert, {Christine M} and David Conen",
year = "2020",
month = jul,
doi = "10.1161/CIRCEP.119.008197",
language = "English",
volume = "13",
journal = "CIRC-ARRHYTHMIA ELEC",
issn = "1941-3149",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

RIS

TY - JOUR

T1 - Canakinumab After Electrical Cardioversion in Patients With Persistent Atrial Fibrillation: A Pilot Randomized Trial

AU - Krisai, Philipp

AU - Blum, Steffen

AU - Schnabel, Renate B

AU - Sticherling, Christian

AU - Kühne, Michael

AU - von Felten, Stefanie

AU - Ammann, Peter

AU - Pruvot, Etienne

AU - Albert, Christine M

AU - Conen, David

PY - 2020/7

Y1 - 2020/7

KW - Anti-Inflammatory Agents/adverse effects

KW - Antibodies, Monoclonal, Humanized/adverse effects

KW - Atrial Fibrillation/diagnosis

KW - Double-Blind Method

KW - Electric Countershock/adverse effects

KW - Female

KW - Heart Rate/drug effects

KW - Humans

KW - Male

KW - Pilot Projects

KW - Recurrence

KW - Risk Factors

KW - Time Factors

KW - Treatment Outcome

U2 - 10.1161/CIRCEP.119.008197

DO - 10.1161/CIRCEP.119.008197

M3 - Other (editorial matter etc.)

C2 - 32536195

VL - 13

JO - CIRC-ARRHYTHMIA ELEC

JF - CIRC-ARRHYTHMIA ELEC

SN - 1941-3149

IS - 7

M1 - e008197

ER -